EUVIMEDEUVIMED entdecken
Crossref

CHD6 promotes triple-negative breast cancer progression and is associated with PI3K/AKT and MAPK pathways

Bokan Chen, Min Zhang, Xia Lin

International Journal of Clinical Oncology · 2026-08 · 31 (8) · 1710-1720

DOI: 10.1007/s10147-026-03085-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 12.06.2026. Verfasst von Bokan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zheji…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Mi-2 Nucleosome Remodeling and Deacetylase Complex. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chromodomain helicase DNA-binding protein 6 (CHD6), a member of the CHD family, is involved in chromatin remodeling and transcriptional regulation, yet its role in cancer remains unclear. This study aimed to investigate the biological function and clinical significance of CHD6 in triple-negative breast cancer (TNBC). MATERIALS AND METHODS: Public datasets were analyzed to evaluate CHD6 expression and prognostic value in TNBC. In vitro assays, including cell proliferation, migration, and invasion, were performed following CHD6 knockdown. A xenograft mouse model was used to assess tumor growth in vivo. Transcriptome sequencing was conducted to explore potential downstream mechanisms. RESULTS: CHD6 expression was significantly upregulated in TNBC tissues and was associated with poor prognosis. CHD6 knockdown markedly inhibited TNBC cell proliferation, migration, and invasion in vitro, and suppressed tumor growth while promoting apoptosis in vivo. Transcriptome analysis suggested that CHD6 downregulation may be associated with altered FGFR3 expression and potential changes in PI3K/AKT and MAPK signaling pathways. CONCLUSION: CHD6 promotes TNBC progression by enhancing tumor cell proliferation and survival. It may also be associated with FGFR3-related signaling pathways. These findings suggest that CHD6 may represent a potential prognostic biomarker and candidate therapeutic target in TNBC, although further mechanistic and translational studies are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMi-2 Nucleosome Remodeling and Deacetylase ComplexHumansFemaleAnimalsCell ProliferationProto-Oncogene Proteins c-aktMicePhosphatidylinositol 3-KinasesPrognosisCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticCell MovementMAP Kinase Signaling SystemApoptosisSignal TransductionBiomarkers, Tumor

Stichwörter der Autor:innen

CHD6FGFR3MigrationProliferationTriple-negative breast cancer

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMi-2 Nucleosome Remodeling and Deacetylase ComplexBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. minzh@zju.edu.cn.
  • Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. xialinzheda@zju.ed…

Zitieren

APA

Chen, B., Zhang, M., & Lin, X. (2026). CHD6 promotes triple-negative breast cancer progression and is associated with PI3K/AKT and MAPK pathways. International Journal of Clinical Oncology, 31(8), 1710-1720. https://doi.org/10.1007/s10147-026-03085-0

Vancouver

Chen B, Zhang M, Lin X. CHD6 promotes triple-negative breast cancer progression and is associated with PI3K/AKT and MAPK pathways. International Journal of Clinical Oncology. 2026;31(8):1710-1720. doi:10.1007/s10147-026-03085-0

BibTeX
@article{Chen2026,
  author = {Chen, Bokan and Zhang, Min and Lin, Xia},
  title = {CHD6 promotes triple-negative breast cancer progression and is associated with PI3K/AKT and MAPK pathways},
  journal = {International Journal of Clinical Oncology},
  year = {2026},
  volume = {31},
  number = {8},
  pages = {1710--1720},
  doi = {10.1007/s10147-026-03085-0}
}
Kostenlos starten →